Kaye I. Foster-Cheek

Companies

• Prime Medicine, Inc.Board member Oct 19, 2022 to now¹
• Agios PharmaceuticalsBoard member Dec 10, 2014 to now²
• Onyx PharmaceuticalsSVP, Global Human Resources Oct 1, 2010 to Oct 3, 2013³
• Johnson & JohnsonVP, Human Resources Feb 15, 2006 to Jan 5, 2010⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Agios Pharmaceuticals AGIO12,484 shares⁵$429.0K at $34.36Jun 23, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 18, 2026Exercised options 2,816 shares of Agios Pharmaceuticals⁵
• Jun 20, 2025Exercised options 2,120 shares of Agios Pharmaceuticals⁶
• Jun 13, 2024Gift 3,564 shares of Agios Pharmaceuticals⁷
• Jun 13, 2024Exercised options 3,388 shares of Agios Pharmaceuticals⁷
• Mar 7, 2024Sold 1,285 shares at $31.62 of Agios Pharmaceuticals⁸
• Mar 6, 2024Sold 4,415 shares at $31.99 of Agios Pharmaceuticals⁹
• Mar 5, 2024Sold 300 shares at $32.21 of Agios Pharmaceuticals⁹
• Aug 9, 2023Sold 25,000 shares at $25.96 of Agios Pharmaceuticals¹⁰
• Aug 9, 2023Exercised options 25,000 shares at $18.09 of Agios Pharmaceuticals¹⁰
• Jun 21, 2023Exercised options 4,975 shares of Agios Pharmaceuticals¹¹
• Jan 13, 2023Gift 2,200 shares of Agios Pharmaceuticals¹²
• May 20, 2022Exercised options 1,585 shares of Agios Pharmaceuticals¹³